Journal of Pharmaceutical Sciences & Emerging DrugsISSN: 2380-9477

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Proteases produced by micromycetes of genus Aspergillus with promising activity for diagnosing and treating the hemostasis system dysfunction diseases


Timorshina S N, Rakova A I, Popova E A, Zvonareva E S, Orechova A V and Osmolovskiy AA

Biological faculty of Lomonosov Moscow State University, Russia

: J Pharm Sci Emerg Drugs

Abstract


Statement of the Problem: In diagnosing and treating the hemostasis system dysfunction diseases preparations based on proteases of animal origin are used since they have a higher specificity compared to bacteria-synthesized enzymes; yet, their disadvantage comes at high cost. Therefore, searching for protease-producers active against the proteins of human hemostasis system and revealing their properties is challenging for modern biomedicine. Methodology & Theoretical Orientation: Here micromycetes of the genus Aspergillus were screened for ability to synthesize extracellular proteases with promising activity for designing anti-thrombotic preparations. For isolation, purification and study of physicochemical properties of proteases, standard methods were used (salting out, electrophoresis, isoelectrofocusing). Enzyme activity was measured spectrophotometrically using native proteins (fibrin, fibrinogen) and chromogenic peptide substrates (HD-Val-Leu-Lys-pNA, pGlu-Pro-Arg-pNA). Findings: As a result of the screening, 3 active producers were selected: Aspergillus alliaceus 7dN1, A. ustus 1, A. terreus 2. The studied extracellular proteases, produced by these micromycetes, had a molecular weight of 30, 33, 34 kDa and isoelectric point of 8.21, 5.10, 4.71, respectively. The protease of micromycete A. ustus 1 showed the greatest fibrinolytic activity (134.4 μm Tyr/ml*min), and the enzyme produced by A. alliaceus 7dN1 has the maximum fibrinogenolytic activity (184.0 μm Tyr/ml*min). The extracellular protease of A. terreus 2 possessed the highest plasmin-like activity (54.1 nmol pNA/ml*min), but the activity against native proteins was relatively low: fibrinolytic - 25.2 μm Tyr/ml*min, fibrinogenolytic - 85.9 μm Tyr/ml*min. However, the ability of A. terreus 2 protease to activate the key factor of human anticoagulant hemostasis system — protein C (39.8 nmol pNA/ml*min) was shown. Conclusion & Significance: Thus, the proteases of micromycetes of the genus Aspergillus as components for enzyme antithrombotic preparations are promising. They were demonstrated to have a broad substrate specificity of extracellular proteases produced by various micromycetes, combined with economic advantage of cultivating these producers.

Biography


E-mail: timorshina.svetlana@mail.ru

Track Your Manuscript

Awards Nomination

GET THE APP